clinical-trial is the sole category represented across all 1 tracked stories. CaringAI is most often covered alongside AAIC 2026, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. CaringAI appears in 1 tracked Biotech story from July 13, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about CaringAI
clinical-trial is the sole category represented across all 1 tracked stories. CaringAI is most often covered alongside AAIC 2026, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. CaringAI appears in 1 tracked Biotech story from July 13, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering CaringAI. Shared-story counts are live from our verified record — not editorial picks.
At AAIC 2026, CaringAI presented research showing 80% concordance between its AI telephone assessment and clinical review, providing early validation for a digital biomarker in cognitive screening.